FOR IMMEDIATE RELEASE – ALPCO’s Winter 2022 Diabetes Research Travel Grant has been awarded to Anoop Arunagiri, PhD, a Research Investigator at the University of Michigan.

Dr. Arunagiri’s research is centered on studying proinsulin misfolding in pancreatic beta cells, and delineating the events and factors contributing to misfolding in the context of diabetes.

ALPCO (Salem, NH) announced its support of the Ukrainian people in a company-wide communication to its employees. The message outlined the company's contribution to aid refugees through the American Red Cross and Project Hope in the amount of $5,000 each. Additionally, ALPCO is offering an unlimited match to all its employees’ contributions to humanitarian aid organizations. As of March 14, ...

FOR IMMEDIATE RELEASE Salem, NH – February 1, 2022: ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing solutions for allergies (IgE-based) and food intolerances (IgG-based), from test material to prop...

Salem, NH, October 12, 2021 [caption id="attachment_7170" align="alignleft" width="229"] Mollie Huber, Summer 2021 Diabetes Research Travel Grant Recipient[/caption] FOR IMMEDIATE RELEASE – ALPCO’s Summer 2021 Diabetes Research Travel Grant has been awarded to Mollie Huber, a fourth year PhD candidate in the Biomedical Sciences program at the University of Florida. Mollie’s novel resea...

We’re excited to announce that ALPCO will be exhibiting at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo at the Georgia World Congress Center in Atlanta, GA from September 28-30. We will be showcasing our growing menu of clinical test kits at booth 3431. Stop by to learn more about an exclusive AACC evaluation promotion for stool-based GI biomarker kits which includes two free...

Salem, NH, April 14, 2020 FOR IMMEDIATE RELEASE – Today ALPCO announced Xi Wang, a PhD candidate at Cornell University, as the latest recipient of its Diabetes Research Travel Grant. Xi’s research focuses on the development of a transplantable encapsulation device for the safe delivery of functional, insulin-producing beta cells. She developed a tubular, Nanofiber Integrated Cell Encapsul...

FOR IMMEDIATE RELEASE Salem, NH – September 21, 2020: American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the expansion of the company’s diagnostics test kit offerin...

Salem, NH, April 14, 2020 FOR IMMEDIATE RELEASE – Today ALPCO announced Marlena Holter from Cornell University, College of Veterinary Medicine as the latest recipient of its Diabetes Research Travel Grant. Ms. Holter is a DVM/PhD candidate in the Biomedical and Biological Sciences Program researching GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define t...

Salem, NH, September 23, 2019 FOR IMMEDIATE RELEASE - Today ALPCO announced that the latest recipient of its Young Investigator Award: The Diabetes Research Travel Grant is Daniel M. Tremmel from the University of Wisconsin. Mr. Tremmel is a PhD student in the Cellular and Molecular Biology Program researching methods to improve the 3D in vitro culture of stem cell derived beta cells for tra...

February 5, 2019 ALPCO announced the latest recipient of its Young Investigator Award, the Diabetes Travel Grant. The grant was created to help advance progressive diabetes and obesity research by graduate students, postdoctoral fellows, and early stage investigators. The program seeks to stimulate and reward research applicable to the investigation and potential development of diabetes and ...